{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:43:21Z","timestamp":1792795401588,"version":"4.5.0"},"reference-count":249,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G035517N"],"award-info":[{"award-number":["G035517N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G086521N"],"award-info":[{"award-number":["G086521N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004727","name":"Vlaams Instituut voor Biotechnologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005026","name":"Foundation Against Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bcp.2021.114747","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T10:46:09Z","timestamp":1629974769000},"page":"114747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":204,"special_numbering":"C","title":["Polo-like kinase 1 (PLK1) signaling in cancer and beyond"],"prefix":"10.1016","volume":"193","author":[{"given":"Styliani","family":"Iliaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5704-582X","authenticated-orcid":false,"given":"Rudi","family":"Beyaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8894-5305","authenticated-orcid":false,"given":"Inna S.","family":"Afonina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bcp.2021.114747_b0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/cm.21504","article-title":"Regulating a key mitotic regulator, polo-like kinase 1 (PLK1)","volume":"75","author":"Colicino","year":"2018","journal-title":"Cytoskeleton."},{"issue":"35","key":"10.1016\/j.bcp.2021.114747_b0010","doi-asserted-by":"crossref","first-page":"36841","DOI":"10.1074\/jbc.M313681200","article-title":"Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex\/Cdc20 activation and initiation of cytokinesis","volume":"279","author":"Van Vugt","year":"2004","journal-title":"J Biol Chem."},{"issue":"7","key":"10.1016\/j.bcp.2021.114747_b0015","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1158\/1535-7163.MCT-15-0897","article-title":"Plk1 inhibitors in cancer therapy: from laboratory to clinics","volume":"15","author":"Gutteridge","year":"2016","journal-title":"Mol Cancer Ther."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tranon.2016.10.003","article-title":"PLK1, A potential target for cancer therapy","volume":"10","author":"Liu","year":"2017","journal-title":"Transl Oncol."},{"issue":"8","key":"10.1016\/j.bcp.2021.114747_b0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrd3184","article-title":"Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy","volume":"9","author":"Strebhardt","year":"2010","journal-title":"Nat Rev Drug Discov."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbcan.2016.02.003","article-title":"PLK-1: angel or devil for cell cycle progression","volume":"1865","author":"Kumar","year":"2016","journal-title":"Biochim Biophys Acta - Rev Cancer."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.molcel.2018.11.010","article-title":"RIPK1 and caspase-8 ensure chromosome stability independently of their role in cell death and inflammation","volume":"73","author":"Liccardi","year":"2019","journal-title":"Mol Cell."},{"key":"10.1016\/j.bcp.2021.114747_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15689-9","article-title":"Proper chromosome alignment depends on BRCA2 phosphorylation by PLK1","author":"Ehl\u00e9n","year":"2020","journal-title":"Nat Commun."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0045","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/15548627.2016.1263781","article-title":"PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy","volume":"13","author":"Ruf","year":"2017","journal-title":"Autophagy."},{"key":"10.1016\/j.bcp.2021.114747_b0050","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.2147\/OTT.S210575","article-title":"PLK1 contributes to autophagy by regulating MYC stabilization in osteosarcoma cells","volume":"12","author":"Mo","year":"2019","journal-title":"Onco Targets Ther."},{"issue":"12","key":"10.1016\/j.bcp.2021.114747_b0055","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1158\/0008-5472.CAN-16-2787","article-title":"Plk1 phosphorylation of Mre11 antagonizes the DNA damage response","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0060","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/onc.2017.379","article-title":"Plk1 phosphorylation of numb leads to impaired DNA damage response","volume":"37","author":"Shao","year":"2018","journal-title":"Oncogene."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12026-015-8778-2","article-title":"Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells","volume":"64","author":"Berges","year":"2016","journal-title":"Immunol Res."},{"issue":"13","key":"10.1016\/j.bcp.2021.114747_b0070","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1111\/jcmm.15356","article-title":"PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt\/\u03b2-catenin signalling pathway","volume":"24","author":"Chen","year":"2020","journal-title":"J Cell Mol Med."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0075","doi-asserted-by":"crossref","first-page":"11355","DOI":"10.1038\/s41598-018-29319-4","article-title":"Hippo signaling pathway dysregulation in human huntington\u2019s disease brain and neuronal stem cells","volume":"8","author":"Mueller","year":"2018","journal-title":"Sci Rep."},{"issue":"9","key":"10.1016\/j.bcp.2021.114747_b0080","doi-asserted-by":"crossref","first-page":"846","DOI":"10.18632\/aging.100382","article-title":"Inhibition of polo-like kinase 1 reduces beta-amyloid-induced neuronal cell death in alzheimer\u2019s disease","volume":"3","author":"Song","year":"2011","journal-title":"Aging."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0085","first-page":"27","volume":"19","author":"Chopra","year":"2009","journal-title":"Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics."},{"issue":"14","key":"10.1016\/j.bcp.2021.114747_b0090","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.91.14.6388","article-title":"Sak, a murine protein-serine\/threonine kinase that is related to the drosophila polo kinase and involved in cell proliferation","volume":"91","author":"Fode","year":"1994","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"32","key":"10.1016\/j.bcp.2021.114747_b0095","doi-asserted-by":"crossref","first-page":"19402","DOI":"10.1074\/jbc.271.32.19402","article-title":"Prk, a cytokine-inducible human protein serine\/threonine kinase whose expression appears to be down-regulated in lung carcinomas","volume":"271","author":"Li","year":"1996","journal-title":"J Biol Chem."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/10425170109041337","article-title":"Identification of the human homologue of the early-growth response gene Snk, encoding a serum-inducible kinase","volume":"11","author":"Liby","year":"2001","journal-title":"DNA Seq."},{"issue":"9","key":"10.1016\/j.bcp.2021.114747_b0105","first-page":"4164","article-title":"Identification of an early-growth-response gene encoding a novel putative protein kinase","volume":"12","author":"Simmons","year":"1992","journal-title":"Mol Cell Biol."},{"issue":"17","key":"10.1016\/j.bcp.2021.114747_b0110","doi-asserted-by":"crossref","first-page":"10351","DOI":"10.1074\/jbc.270.17.10351","article-title":"Identification by targeted differential display of an immediate early gene encoding a putative serine\/threonine kinase","volume":"270","author":"Donohue","year":"1995","journal-title":"J Biol Chem."},{"issue":"13","key":"10.1016\/j.bcp.2021.114747_b0115","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.cub.2004.06.059","article-title":"Polo-like kinase-2 is required for centriole duplication in mammalian cells","volume":"14","author":"Warnke","year":"2004","journal-title":"Curr Biol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114747_b0120","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ncb1320","article-title":"The Polo kinase Plk4 functions in centriole duplication","volume":"7","author":"Habedanck","year":"2005","journal-title":"Nat Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0125","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1073\/pnas.0610856104","article-title":"Polo-like kinase 3 is required for entry into S phase","volume":"104","author":"Zimmerman","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"46","key":"10.1016\/j.bcp.2021.114747_b0130","doi-asserted-by":"crossref","first-page":"43305","DOI":"10.1074\/jbc.M106050200","article-title":"Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway","volume":"276","author":"Xie","year":"2001","journal-title":"J Biol Chem."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0135","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/MCB.00607-10","article-title":"Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression","volume":"31","author":"de Carcer","year":"2011","journal-title":"Mol Cell Biol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114747_b0140","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00018-010-0279-9","article-title":"Polo-box domain : a versatile mediator of polo-like kinase function","volume":"67","author":"Park","year":"2011","journal-title":"Cell Mol Life Sci."},{"issue":"5610","key":"10.1016\/j.bcp.2021.114747_b0145","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1079079","article-title":"Proteomic screen finds pSer\/pThr-binding domain localizing Plk1 to mitotic substrates","volume":"299","author":"Elia","year":"2003","journal-title":"Science."},{"issue":"9","key":"10.1016\/j.bcp.2021.114747_b0150","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/sj.emboj.7601683","article-title":"Proteomic screen defines the polo-box domain interactome and identifies Rock2 as a Plk1 substrate","volume":"26","author":"Lowery","year":"2007","journal-title":"EMBO J."},{"issue":"16","key":"10.1016\/j.bcp.2021.114747_b0155","doi-asserted-by":"crossref","first-page":"9301","DOI":"10.1073\/pnas.95.16.9301","article-title":"Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk","volume":"95","author":"Lee","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"10.1016\/j.bcp.2021.114747_b0160","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1128\/MCB.01663-08","article-title":"Functional dynamics of polo-like kinase 1 at the centrosome","volume":"29","author":"Kishi","year":"2009","journal-title":"Mol Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0092-8674(03)00725-6","article-title":"The molecular basis for phosphodependent substrate targeting and regulation of Plks by the polo-box domain","volume":"115","author":"Elia","year":"2003","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.molcel.2006.10.016","article-title":"Self-Regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation","volume":"24","author":"Kang","year":"2006","journal-title":"Mol Cell."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000111","article-title":"Plk1 self-organization and priming phosphorylation of HsCYK-4 at the spindle midzone regulate the onset of division in human cells","volume":"7","author":"Burkard","year":"2009","journal-title":"PLoS Biol."},{"issue":"33","key":"10.1016\/j.bcp.2021.114747_b0180","doi-asserted-by":"crossref","first-page":"11663","DOI":"10.1073\/pnas.0500410102","article-title":"Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways","volume":"102","author":"Watanabe","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"17","key":"10.1016\/j.bcp.2021.114747_b0185","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1101\/gad.436007","article-title":"Tension-sensitive Plk1 phosphorylation on BubR1 regulates the stability of kinetochore-microtubule interactions","volume":"21","author":"Elowe","year":"2007","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0190","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/embo-reports\/kvf069","article-title":"Plk1 promotes nuclear translocation of human Cdc25C during prophase","volume":"3","author":"Toyoshima-Morimoto","year":"2002","journal-title":"EMBO Rep."},{"issue":"54","key":"10.1016\/j.bcp.2021.114747_b0195","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1038\/sj.onc.1206011","article-title":"Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1","volume":"21","author":"Yuan","year":"2002","journal-title":"Oncogene."},{"issue":"28","key":"10.1016\/j.bcp.2021.114747_b0200","doi-asserted-by":"crossref","first-page":"25277","DOI":"10.1074\/jbc.C300126200","article-title":"Identification of a consensus motif for PlK (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate","volume":"278","author":"Nakojima","year":"2003","journal-title":"J Biol Chem."},{"issue":"20","key":"10.1016\/j.bcp.2021.114747_b0205","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1021\/bi602474j","article-title":"Structure of the catalytic domain of human polo-like kinase 1","volume":"46","author":"Kothe","year":"2007","journal-title":"Biochemistry."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b0210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4161\/cc.3.2.660","article-title":"The Polo-box domain: a molecular integrator of mitotic kinase cascades and polo-like kinase function","volume":"3","author":"Lowery","year":"2004","journal-title":"Cell Cycle."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0215","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/bib\/bbs041","article-title":"Systematic analysis of the Plk-mediated phosphoregulation in eukaryotes","volume":"14","author":"Liu","year":"2013","journal-title":"Brief Bioinform."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0220","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/MCB.17.6.3408","article-title":"Plk is a functional homolog of saccharomyces cerevisiae Cdc5, and elevated Plk activity induces multiple septation structures","volume":"17","author":"Lee","year":"1997","journal-title":"Mol Cell Biol."},{"issue":"46","key":"10.1016\/j.bcp.2021.114747_b0225","doi-asserted-by":"crossref","first-page":"44115","DOI":"10.1074\/jbc.M202172200","article-title":"Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase","volume":"277","author":"Jang","year":"2002","journal-title":"J Biol Chem."},{"issue":"5883","key":"10.1016\/j.bcp.2021.114747_b0230","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.1157425","article-title":"Bora and the kinase aurora a cooperatively activate the kinase Plk1 and control mitotic entry","volume":"320","author":"Seki","year":"2008","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0235","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41467-017-01876-8","article-title":"Coupling of polo kinase activation to nuclear localization by a bifunctional NLS is required during mitotic entry","volume":"8","author":"Kachaner","year":"2017","journal-title":"Nat Commun."},{"key":"10.1016\/j.bcp.2021.114747_b0240","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/ncomms2879","article-title":"PI 3-kinase-dependent phosphorylation of Plk1-Ser99 promotes association with 14-3-3\u03b3 and is required for metaphase-anaphase transition","volume":"4","author":"Kasahara","year":"2013","journal-title":"Nat Commun."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0245","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1083\/jcb.201205090","article-title":"Polo-like kinase-1 regulates kinetochore-microtubule dynamics and spindle checkpoint silencing","volume":"198","author":"Liu","year":"2012","journal-title":"J Cell Biol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114747_b0250","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/ncb2327","article-title":"Formation of stable attachments between kinetochores and microtubules depends on the B56-PP2A phosphatase","volume":"13","author":"Foley","year":"2011","journal-title":"Nat Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0255","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.devcel.2008.02.013","article-title":"Myosin phosphatase-targeting subunit 1 regulates mitosis by antagonizing polo-like kinase 1","volume":"14","author":"Yamashiro","year":"2008","journal-title":"Dev Cell."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0260","article-title":"Cyclin A\/Cdk1 modulates Plk1 activity in prometaphase to regulate kinetochore-microtubule attachment stability","volume":"20","author":"Dumitru","year":"2017","journal-title":"Elife."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0265","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/mrd.10289","article-title":"Cell cycle dependent expression of Plk1 in synchronized porcine fetal fibroblasts","volume":"65","author":"Anger","year":"2003","journal-title":"Mol Reprod Dev."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b0270","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1083\/jcb.200309035","article-title":"Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells","volume":"164","author":"Lindon","year":"2004","journal-title":"J Cell Biol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b0275","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cell.2008.05.043","article-title":"The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint","volume":"134","author":"Bassermann","year":"2008","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0280","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ncb2695","article-title":"Ubiquitylation-dependent localization of PLK1 in mitosis","volume":"15","author":"Beck","year":"2013","journal-title":"Nat Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0285","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1083\/jcb.201502044","article-title":"Usp16 regulates kinetochore localization of Plk1 to promote proper chromosome alignment in mitosis","volume":"210","author":"Zhuo","year":"2015","journal-title":"J Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0290","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.devcel.2016.04.023","article-title":"The centrosome undergoes Plk1-independent interphase maturation during inflammation and mediates cytokine release","volume":"37","author":"Vertii","year":"2016","journal-title":"Dev Cell."},{"issue":"15","key":"10.1016\/j.bcp.2021.114747_b0295","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1128\/MCB.00068-15","article-title":"Bimodal interaction of mammalian polo-like kinase 1 and a centrosomal Scaffold, Cep192, in the regulation of bipolar spindle formation","volume":"35","author":"Meng","year":"2015","journal-title":"Mol Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0300","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00412-008-0165-5","article-title":"Plk1 regulates mitotic aurora a function through betaTrCP-dependent degradation of hBora","volume":"117","author":"Chan","year":"2008","journal-title":"Chromosoma."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0305","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4161\/cc.5.3.2392","article-title":"A functional interplay between aurora-a, Plk1 and TPX2 at spindle poles: Plk1 controls centrosomal localization of aurora-a and TPX2 spindle association","volume":"5","author":"De Luca","year":"2006","journal-title":"Cell Cycle."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0310","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1091\/mbc.E17-08-0524","article-title":"Gravin regulates centrosome function through PLK1","volume":"29","author":"Colicino","year":"2018","journal-title":"Mol Biol Cell."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0315","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.devcel.2009.02.004","article-title":"Plk1-dependent and -independent roles of an ODF2 splice variant, hCenexin1, at the centrosome of somatic cells","volume":"16","author":"Soung","year":"2009","journal-title":"Dev Cell."},{"issue":"13","key":"10.1016\/j.bcp.2021.114747_b0320","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.cub.2011.05.047","article-title":"Plk1 controls the Nek2A-PP1\u03b3 antagonism in centrosome disjunction","volume":"21","author":"Mardin","year":"2011","journal-title":"Curr Biol."},{"key":"10.1016\/j.bcp.2021.114747_b0325","doi-asserted-by":"crossref","unstructured":"Lane HA, Nigg EA. Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J Cell Biol. 1996;135(6 II):1701\u201313.","DOI":"10.1083\/jcb.135.6.1701"},{"issue":"19","key":"10.1016\/j.bcp.2021.114747_b0330","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.cub.2004.09.049","article-title":"Roles of polo-like kinase 1 in the assembly of functional mitotic spindles","volume":"14","author":"Sumara","year":"2004","journal-title":"Curr Biol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114747_b0335","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1083\/jcb.201106093","article-title":"PLK1 phosphorylation of pericentrin initiates centrosome maturation at the onset of mitosis","volume":"195","author":"Lee","year":"2011","journal-title":"J Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0340","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.devcel.2009.07.015","article-title":"Polo kinase and separase regulate the mitotic licensing of centriole duplication in human cells","volume":"17","author":"Tsou","year":"2009","journal-title":"Dev Cell."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms10076","article-title":"PLK1 regulation of PCNT cleavage ensures fidelity of centriole separation during mitotic exit","volume":"6","author":"Kim","year":"2015","journal-title":"Nat Commun."},{"issue":"13","key":"10.1016\/j.bcp.2021.114747_b0350","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.4161\/cc.20878","article-title":"Separase-dependent cleavage of pericentrin B is necessary and sufficient for centriole disengagement during mitosis","volume":"11","author":"Lee","year":"2012","journal-title":"Cell Cycle."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0355","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1083\/jcb.201108006","article-title":"Breaking the ties that bind: new advances in centrosome biology","volume":"197","author":"Mardin","year":"2012","journal-title":"J Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0360","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1074\/jbc.M116.765438","article-title":"Daz-interacting protein 1 (Dzip1) phosphorylation by polo-like kinase 1 (Plk1) regulates the centriolar satellite localization of the BBSome protein during the cell cycle","volume":"292","author":"Zhang","year":"2017","journal-title":"J Biol Chem."},{"issue":"Pt 6","key":"10.1016\/j.bcp.2021.114747_b0365","first-page":"1355","article-title":"PCM1 recruits Plk1 to the pericentriolar matrix to promote primary cilia disassembly before mitotic entry","volume":"126","author":"Wang","year":"2013","journal-title":"J Cell Sci."},{"issue":"7","key":"10.1016\/j.bcp.2021.114747_b0370","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cell.2007.04.035","article-title":"HEF1-dependent aurora a activation induces disassembly of the primary cilium","volume":"129","author":"Pugacheva","year":"2007","journal-title":"Cell."},{"issue":"14","key":"10.1016\/j.bcp.2021.114747_b0375","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1038\/emboj.2012.144","article-title":"Identification of a novel Wnt5a-CK1\u03b5-Dvl2-Plk1-mediated primary cilia disassembly pathway","volume":"31","author":"Lee","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2021.114747_b0380","doi-asserted-by":"crossref","unstructured":"Ishikawa H, Marshall WF. Ciliogenesis: Building the cell\u2019s antenna Nat Rev Mol Cell Biol. 2011;12(4):222-34.","DOI":"10.1038\/nrm3085"},{"issue":"10","key":"10.1016\/j.bcp.2021.114747_b0385","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.celrep.2017.05.031","article-title":"PLK1 activation in late G2 sets up commitment to mitosis","volume":"19","author":"Gheghiani","year":"2017","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0390","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.devcel.2018.05.005","article-title":"Cyclin A-cdk1-dependent phosphorylation of bora is the triggering factor promoting mitotic entry","volume":"45","author":"Vigneron","year":"2018","journal-title":"Dev Cell."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0395","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.emboj.7600567","article-title":"The Polo-like kinase Plx1 interacts with and inhibits Myt1 after fertilization of Xenopus eggs","volume":"24","author":"Inoue","year":"2005","journal-title":"EMBO J."},{"issue":"6825","key":"10.1016\/j.bcp.2021.114747_b0400","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/35065617","article-title":"Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase","volume":"410","author":"Toyoshima-Morimoto","year":"2001","journal-title":"Nature."},{"issue":"21","key":"10.1016\/j.bcp.2021.114747_b0405","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1073\/pnas.0703268104","article-title":"The tumor suppressor CYLD regulates entry into mitosis","volume":"104","author":"Stegmeier","year":"2007","journal-title":"Proc Natl Acad Sci."},{"issue":"14","key":"10.1016\/j.bcp.2021.114747_b0410","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.cub.2006.05.052","article-title":"Yu-Lee L yuan. NudC Is required for Plk1 targeting to the kinetochore and chromosome congression","volume":"16","author":"Nishino","year":"2006","journal-title":"Curr Biol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b0415","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ncb1350","article-title":"Complex formation of Plk1 and INCENP required for metaphase-anaphase transition","volume":"8","author":"Goto","year":"2006","journal-title":"Nat Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0420","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0092-8674(02)00633-5","article-title":"Evidence that the Ipl1-Sli15 (Aurora kinase-INCENP) complex promotes chromosome bi-orientation by altering kinetochore-spindle pole connections","volume":"108","author":"Tanaka","year":"2002","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0425","doi-asserted-by":"crossref","first-page":"8794","DOI":"10.1038\/s41598-017-09114-3","article-title":"Plk1 bound to Bub1 contributes to spindle assembly checkpoint activity during mitosis","volume":"7","author":"Ikeda","year":"2017","journal-title":"Sci Rep."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0430","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fcell.2018.00062","article-title":"Kinase and phosphatase cross-talk at the kinetochore","volume":"19","author":"Saurin","year":"2018","journal-title":"Front Cell Dev Biol."},{"key":"10.1016\/j.bcp.2021.114747_b0435","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1146\/annurev-biochem-061611-090435","article-title":"The MPS1 family of protein kinases","volume":"81","author":"Liu","year":"2012","journal-title":"Annu Rev Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0440","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.celrep.2015.06.007","article-title":"Plk1 and Mps1 cooperatively regulate the spindle assembly checkpoint in human cells","volume":"12","author":"von Schubert","year":"2015","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.bcp.2021.114747_b0445","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202002020","article-title":"Kinetochore phosphatases suppress autonomous polo-like kinase 1 activity to control the mitotic checkpoint","volume":"219","author":"Cordeiro","year":"2020","journal-title":"J Cell Biol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114747_b0450","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1091\/mbc.e04-07-0598","article-title":"Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCF\u03b2TrCP_ dependent destruction of the APC inhibitor Emi1","volume":"15","author":"Hansen","year":"2004","journal-title":"Mol Biol Cell."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0455","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800223","article-title":"Plk1 regulates spindle orientation by phosphorylating NuMA in human cells","volume":"1","author":"Sana","year":"2018","journal-title":"Life Sci Alliance."},{"key":"10.1016\/j.bcp.2021.114747_b0460","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.241281","article-title":"The centriole protein CEP76 negatively regulates PLK1 activity in the cytoplasm for proper mitotic progression","author":"Takeda","year":"2020","journal-title":"J Cell Sci."},{"issue":"5716","key":"10.1016\/j.bcp.2021.114747_b0465","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.1096896","article-title":"The molecular requirements for cytokinesis","volume":"307","author":"Glotzer","year":"2005","journal-title":"Science."},{"key":"10.1016\/j.bcp.2021.114747_b0470","doi-asserted-by":"crossref","unstructured":"Nishimura Y, Yonemura S. Centralspindlin regulates ECT2 and RhoA accumulation at the equatorial cortex during cytokinesis. J Cell Sci. 2006;119(1):104 LP \u2013 114.","DOI":"10.1242\/jcs.02737"},{"issue":"7002","key":"10.1016\/j.bcp.2021.114747_b0475","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nature02767","article-title":"Cell cycle regulation of central spindle assembly","volume":"430","author":"Mishima","year":"2004","journal-title":"Nature."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0480","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.devcel.2007.03.013","article-title":"Polo-like Kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle","volume":"12","author":"Petronczki","year":"2007","journal-title":"Dev Cell."},{"issue":"18","key":"10.1016\/j.bcp.2021.114747_b0485","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.4161\/15384101.2014.947201","article-title":"Centralspindlin assembly and 2 phosphorylations on MgcRacGAP by polo-like kinase 1 initiate Ect2 binding in early cytokinesis","volume":"13","author":"Kim","year":"2014","journal-title":"Cell Cycle."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0490","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1083\/jcb.200306009","article-title":"Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis","volume":"162","author":"Neef","year":"2003","journal-title":"J Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0495","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ncb1557","article-title":"Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1","volume":"9","author":"Neef","year":"2007","journal-title":"Nat Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0500","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1083\/jcb.201805036","article-title":"PLK1 plays dual roles in centralspindlin regulation during cytokinesis","volume":"218","author":"Adriaans","year":"2019","journal-title":"J Cell Biol."},{"issue":"5833","key":"10.1016\/j.bcp.2021.114747_b0505","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1126\/science.1143422","article-title":"Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery","volume":"316","author":"Carlton","year":"2007","journal-title":"Science."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0510","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1083\/jcb.201008108","article-title":"Plk1 negatively regulates Cep55 recruitment to the midbody to ensure orderly abscission","volume":"191","author":"Bastos","year":"2010","journal-title":"J Cell Biol."},{"issue":"20","key":"10.1016\/j.bcp.2021.114747_b0515","doi-asserted-by":"crossref","first-page":"13466","DOI":"10.1074\/jbc.M809471200","article-title":"The minichromosome maintenance proteins 2\u20137 (MCM2-7) are necessary for RNA polymerase II (Pol II)-mediated transcription","volume":"284","author":"Snyder","year":"2009","journal-title":"J Biol Chem."},{"issue":"23","key":"10.1016\/j.bcp.2021.114747_b0520","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1128\/MCB.06110-11","article-title":"Plk1 phosphorylation of Orc2 promotes DNA replication under conditions of stress","volume":"31","author":"Song","year":"2011","journal-title":"Mol Cell Biol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114747_b0525","doi-asserted-by":"crossref","first-page":"11943","DOI":"10.1074\/jbc.M413514200","article-title":"Interaction of chromatin-associated Plk1 and Mcm7","volume":"280","author":"Tsvetkov","year":"2005","journal-title":"J Biol Chem."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0530","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1073\/pnas.0712063105","article-title":"Role for Plk1 phosphorylation of Hbo1 in regulation of replication licensing","volume":"105","author":"Wu","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0535","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/emboj.2008.29","article-title":"Plx1 is required for chromosomal DNA replication under stressful conditions","volume":"27","author":"Trenz","year":"2008","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.bcp.2021.114747_b0540","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1128\/MCB.01277-08","article-title":"Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation","volume":"29","author":"Yim","year":"2009","journal-title":"Mol Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0545","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molcel.2018.05.026","article-title":"DNA replication determines timing of mitosis by restricting CDK1 and PLK1 activation","volume":"71","author":"Lemmens","year":"2018","journal-title":"Mol Cell."},{"issue":"11","key":"10.1016\/j.bcp.2021.114747_b0550","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/cr.2013.127","article-title":"Centrosomal protein FOR20 is essential for S-phase progression by recruiting Plk1 to centrosomes","volume":"23","author":"Shen","year":"2013","journal-title":"Cell Res."},{"issue":"10","key":"10.1016\/j.bcp.2021.114747_b0555","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1074\/jbc.M709007200","article-title":"Plk1-dependent phosphorylation regulates functions of DNA topoisomerase II\u03b1 in cell cycle progression","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0560","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.molcel.2007.11.015","article-title":"The DNA damage response: ten years after","volume":"28","author":"Harper","year":"2007","journal-title":"Mol Cell."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0565","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat Rev Cancer."},{"issue":"5470","key":"10.1016\/j.bcp.2021.114747_b0570","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1126\/science.288.5470.1425","article-title":"Rapid destruction of human Cdc25A in response to DNA damage","volume":"288","author":"Mailand","year":"2000","journal-title":"Science."},{"key":"10.1016\/j.bcp.2021.114747_b0575","doi-asserted-by":"crossref","unstructured":"Thanasoula M, Escandell JM, Suwaki N, Tarsounas M. ATM\/ATR checkpoint activation downregulates CDC25C to prevent mitotic entry with uncapped telomeres. EMBO J. 2012\/07\/27. 2012;31(16):3398\u2013410.","DOI":"10.1038\/emboj.2012.191"},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0580","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4161\/cc.4.1.1348","article-title":"Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage","volume":"4","author":"Tsvetkov","year":"2005","journal-title":"Cell Cycle."},{"issue":"9","key":"10.1016\/j.bcp.2021.114747_b0585","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/35023629","article-title":"Polo-like kinase-1 is a target of the DNA damage checkpoint","volume":"2","author":"Smits","year":"2000","journal-title":"Nat Cell Biol."},{"issue":"13","key":"10.1016\/j.bcp.2021.114747_b0590","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/onc.2016.347","article-title":"Inhibition of polo-like kinase 1 during the DNA damage response is mediated through loss of aurora a recruitment by bora","volume":"36","author":"Bruinsma","year":"2017","journal-title":"Oncogene."},{"issue":"22","key":"10.1016\/j.bcp.2021.114747_b0595","doi-asserted-by":"crossref","first-page":"16139","DOI":"10.1074\/jbc.M113.456780","article-title":"Ataxia telangiectasia-mutated- and Rad3-related protein regulates the DNA damage-induced G2\/M checkpoint through the aurora a cofactor bora protein","volume":"288","author":"Qin","year":"2013","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bcp.2021.114747_b0600","article-title":"A methylation-phosphorylation switch determines Plk1 kinase activity and function in DNA damage repair","author":"Li","year":"2019537566","journal-title":"Sci Adv."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0605","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.molcel.2011.12.028","article-title":"Plk1 and CK2 act in concert to regulate Rad51 during DNA double strand break repair","volume":"45","author":"Yata","year":"2012","journal-title":"Mol Cell."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b0610","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1083\/jcb.200510130","article-title":"Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks","volume":"173","author":"Bekker-Jensen","year":"2006","journal-title":"J Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0615","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.18632\/oncotarget.6825","article-title":"Polo-like kinase 1 mediates BRCA1 phosphorylation and recruitment at DNA double-strand breaks","volume":"7","author":"Chabalier-Taste","year":"2016","journal-title":"Oncotarget."},{"issue":"14","key":"10.1016\/j.bcp.2021.114747_b0620","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4161\/cc.25349","article-title":"BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress","volume":"12","author":"Zou","year":"2013","journal-title":"Cell Cycle."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0625","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.molcel.2004.07.015","article-title":"Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells","volume":"15","author":"Van Vugt","year":"2004","journal-title":"Mol Cell."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0630","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molcel.2006.06.013","article-title":"SCFbetaTrCP-mediated degradation of claspin regulates recovery from the DNA replication checkpoint response","volume":"23","author":"Peschiaroli","year":"2006","journal-title":"Mol Cell."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0635","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbrc.2012.06.023","article-title":"Novel DNA damage checkpoint in mitosis: mitotic DNA damage induces re-replication without cell division in various cancer cells","volume":"423","author":"Hyun","year":"2012","journal-title":"Biochem Biophys Res Commun."},{"issue":"10","key":"10.1016\/j.bcp.2021.114747_b0640","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/15384101.2019.1617003","article-title":"Dephosphorylation of Plk1 occurs through PP2A-B55\/ENSA\/greatwall pathway during mitotic DNA damage recovery","volume":"18","author":"Kim","year":"2019","journal-title":"Cell Cycle."},{"issue":"21","key":"10.1016\/j.bcp.2021.114747_b0645","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.4161\/cc.9.21.13632","article-title":"A novel role for greatwall kinase in recovery from DNA damage","volume":"9","author":"Peng","year":"2010","journal-title":"Cell Cycle."},{"key":"10.1016\/j.bcp.2021.114747_b0650","doi-asserted-by":"crossref","first-page":"22230","DOI":"10.1038\/srep22230","article-title":"MASTL(Greatwall) regulates DNA damage responses by coordinating mitotic entry after checkpoint recovery and APC\/C activation","volume":"6","author":"Wong","year":"2016","journal-title":"Sci Rep."},{"issue":"43","key":"10.1016\/j.bcp.2021.114747_b0655","doi-asserted-by":"crossref","first-page":"17374","DOI":"10.1073\/pnas.1310745110","article-title":"Greatwall is essential to prevent mitotic collapse after nuclear envelope breakdown in mammals","volume":"110","author":"\u00c1lvarez-Fern\u00e1ndez","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"44","key":"10.1016\/j.bcp.2021.114747_b0660","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1038\/s41388-020-01470-1","article-title":"The Greatwall kinase safeguards the genome integrity by affecting the kinome activity in mitosis","volume":"39","author":"Bisteau","year":"2020","journal-title":"Oncogene."},{"key":"10.1016\/j.bcp.2021.114747_b0665","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.dnarep.2015.04.016","article-title":"CtIP: A DNA damage response protein at the intersection of DNA metabolism","volume":"32","author":"Makharashvili","year":"2015","journal-title":"DNA Repair (Amst)."},{"issue":"20","key":"10.1016\/j.bcp.2021.114747_b0670","first-page":"10724","article-title":"PLK1 targets CtIP to promote microhomology-mediated end joining","volume":"46","author":"Wang","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b0675","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4161\/15384101.2014.977067","article-title":"Polo-like kinase 1 inhibits DNA damage response during mitosis","volume":"14","author":"Benada","year":"2015","journal-title":"Cell Cycle."},{"issue":"47","key":"10.1016\/j.bcp.2021.114747_b0680","doi-asserted-by":"crossref","first-page":"17941","DOI":"10.1074\/jbc.RA119.009881","article-title":"PLK1 targets NOTCH1 during DNA damage and mitotic progression","volume":"294","author":"De","year":"2019","journal-title":"J Biol Chem."},{"issue":"11","key":"10.1016\/j.bcp.2021.114747_b0685","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrm.2016.94","article-title":"Notch signalling in context","volume":"17","author":"Bray","year":"2016","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0690","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in Context","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell."},{"issue":"11","key":"10.1016\/j.bcp.2021.114747_b0695","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.cellsig.2011.06.016","article-title":"Suppression of Polo like kinase 1 (PLK1) by p21Waf1 mediates the p53-dependent prevention of caspase-independent mitotic death","volume":"23","author":"Lin","year":"2011","journal-title":"Cell Signal."},{"issue":"15","key":"10.1016\/j.bcp.2021.114747_b0700","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1016\/j.febslet.2006.05.047","article-title":"Polo-like kinase 1 regulates mitotic arrest after UV irradiation through dephosphorylation of p53 and inducing p53 degradation","volume":"580","author":"Chen","year":"2006","journal-title":"FEBS Lett."},{"issue":"22","key":"10.1016\/j.bcp.2021.114747_b0705","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1016\/j.febslet.2009.09.057","article-title":"Polo-like kinase-1 phosphorylates MDM2 at Ser260 and stimulates MDM2-mediated p53 turnover","volume":"583","author":"Dias","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2021.114747_b0710","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcdb.2015.02.013","article-title":"Mechanism of autophagic regulation in carcinogenesis and cancer therapeutics","volume":"39","author":"Panda","year":"2015","journal-title":"Semin Cell Dev Biol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114747_b0715","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/carcin\/bgr031","article-title":"The multiple roles of autophagy in cancer","volume":"32","author":"Rosenfeldt","year":"2011","journal-title":"Carcinogenesis."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0720","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/EBC20170027","article-title":"mTORC1 as the main gateway to autophagy","volume":"61","author":"Rabanal-Ruiz","year":"2017","journal-title":"Essays Biochem."},{"issue":"19","key":"10.1016\/j.bcp.2021.114747_b0725","doi-asserted-by":"crossref","first-page":"12783","DOI":"10.1074\/jbc.M809207200","article-title":"Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein","volume":"284","author":"Sato","year":"2009","journal-title":"J Biol Chem."},{"issue":"9","key":"10.1016\/j.bcp.2021.114747_b0730","first-page":"2723","article-title":"Knockdown of PLK1 inhibits invasion and promotes apoptosis in glioma cells through regulating autophagy","volume":"22","author":"Wu","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"10.1016\/j.bcp.2021.114747_b0735","article-title":"PLK1 inhibition sensitizes breast cancer cells to radiation via suppressing autophagy","author":"Wang","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0740","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3892\/or.2017.5417","article-title":"Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation","volume":"37","author":"Tao","year":"2017","journal-title":"Oncol Rep."},{"issue":"8","key":"10.1016\/j.bcp.2021.114747_b0745","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/embor.2010.90","article-title":"Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery","volume":"11","author":"Liu","year":"2010","journal-title":"EMBO Rep."},{"issue":"24","key":"10.1016\/j.bcp.2021.114747_b0750","doi-asserted-by":"crossref","first-page":"25549","DOI":"10.1074\/jbc.M314182200","article-title":"Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation","volume":"279","author":"Ando","year":"2004","journal-title":"J Biol Chem."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0755","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.molonc.2013.12.013","article-title":"Sequential Cdk1 and Plk1 phosphorylation of caspase-8 triggers apoptotic cell death during mitosis","volume":"8","author":"Matthess","year":"2014","journal-title":"Mol Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0760","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/onc.2010.423","article-title":"Phosphorylation by polo-like kinase 1 induces the tumor-suppressing activity of FADD","volume":"30","author":"Jang","year":"2011","journal-title":"Oncogene."},{"issue":"13","key":"10.1016\/j.bcp.2021.114747_b0765","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1158\/1078-0432.CCR-10-3236","article-title":"PLK1 is transcriptionally activated by NF-\u03baB during cell detachment and enhances anoikis resistance through inhibiting \u03b2-catenin degradation in esophageal squamous cell carcinoma","volume":"17","author":"Lin","year":"2011","journal-title":"Clin Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0770","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.bbrc.2018.12.182","article-title":"Insulin promotes proliferation of pancreatic ductal epithelial cells by increasing expression of PLK1 through PI3K\/AKT and NF-\u03baB pathway","volume":"509","author":"Wu","year":"2019","journal-title":"Biochem Biophys Res Commun."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0775","first-page":"871","volume":"139","author":"Thiery","year":"2009","journal-title":"Epithelial-Mesenchymal Transitions in Development and Disease Cell."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b0780","article-title":"Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF\/ERK signaling","volume":"22","author":"Wu","year":"2016","journal-title":"Elife."},{"issue":"10","key":"10.1016\/j.bcp.2021.114747_b0785","first-page":"4172","article-title":"PLK1 promotes epithelial-mesenchymal transition and metastasis of gastric carcinoma cells","volume":"8","author":"Cai","year":"2016","journal-title":"Am J Transl Res."},{"issue":"7","key":"10.1016\/j.bcp.2021.114747_b0790","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1158\/1078-0432.CCR-14-2890","article-title":"Epithelial-mesenchymal transition predicts polo-like kinase 1 inhibitor-mediated apoptosis in non-small cell lung cancer","volume":"22","author":"Ferrarotto","year":"2016","journal-title":"Clin Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0795","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41388-019-1023-z","article-title":"Active PLK1-driven metastasis is amplified by TGF-\u03b2 signaling that forms a positive feedback loop in non-small cell lung cancer","volume":"39","author":"Shin","year":"2020","journal-title":"Oncogene."},{"issue":"10","key":"10.1016\/j.bcp.2021.114747_b0800","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1016\/j.bbagen.2014.07.018","article-title":"AKT\/GSK-3\u03b2 regulates stability and transcription of snail which is crucial for bFGF-induced epithelial-mesenchymal transition of prostate cancer cells","volume":"1840","author":"Liu","year":"2014","journal-title":"Biochim Biophys Acta."},{"issue":"51","key":"10.1016\/j.bcp.2021.114747_b0805","doi-asserted-by":"crossref","first-page":"35354","DOI":"10.1074\/jbc.M806258200","article-title":"Regulation of I\u03baB kinase complex by phosphorylation of \u03b3-binding domain of I\u03baB kinase \u03b2 by polo-like kinase 1","volume":"283","author":"Higashimoto","year":"2008","journal-title":"J Biol Chem."},{"issue":"14","key":"10.1016\/j.bcp.2021.114747_b0810","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1091\/mbc.e09-08-0715","article-title":"The scaffold protein TANK\/I-TRAF inhibits NF-\u03baB activation by recruiting polo-like kinase 1","volume":"21","author":"Zhang","year":"2010","journal-title":"Mol Biol Cell."},{"issue":"33","key":"10.1016\/j.bcp.2021.114747_b0815","doi-asserted-by":"crossref","first-page":"21797","DOI":"10.1074\/jbc.M109.018275","article-title":"Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS","volume":"284","author":"Vitour","year":"2009","journal-title":"J Biol Chem."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b0820","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/bbrc.1997.6633","article-title":"Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase","volume":"234","author":"Smith","year":"1997","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0825","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.celrep.2014.10.011","article-title":"The Oncogenic STP Axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor","volume":"9","author":"Karlin","year":"2014","journal-title":"Cell Rep."},{"issue":"33","key":"10.1016\/j.bcp.2021.114747_b0830","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.3748\/wjg.15.4177","article-title":"Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients","volume":"15","author":"He","year":"2009","journal-title":"World J Gastroenterol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b0835","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1349-7006.2003.tb01411.x","article-title":"Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers","volume":"94","author":"Takahashi","year":"2003","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0840","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/pros.20050","article-title":"Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades","volume":"60","author":"Weichert","year":"2004","journal-title":"Prostate."},{"key":"10.1016\/j.bcp.2021.114747_b0845","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/s13104-015-1658-y","article-title":"FOXM1 and polo-like kinase 1 are co-ordinately overexpressed in patients with gastric adenocarcinomas","volume":"8","author":"Dibb","year":"2015","journal-title":"BMC Res Notes."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0850","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjc.6601610","article-title":"Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma","volume":"90","author":"Weichert","year":"2004","journal-title":"Br J Cancer."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0855","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1034\/j.1600-0560.2002.290605.x","article-title":"Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease","volume":"29","author":"Kneisel","year":"2002","journal-title":"J Cutan Pathol."},{"key":"10.1016\/j.bcp.2021.114747_b0860","first-page":"81","article-title":"p53 and human cancer: the first ten thousand mutations","volume":"77","author":"Hainaut","year":"2000","journal-title":"Adv Cancer Res."},{"issue":"28","key":"10.1016\/j.bcp.2021.114747_b0865","doi-asserted-by":"crossref","first-page":"18588","DOI":"10.1074\/jbc.C109.001560","article-title":"Plk1-mediated phosphorylation of topors regulates p53 stability","volume":"284","author":"Yang","year":"2009","journal-title":"J Biol Chem."},{"issue":"7174","key":"10.1016\/j.bcp.2021.114747_b0870","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nature06412","article-title":"NUMB controls p53 tumour suppressor activity","volume":"451","author":"Colaluca","year":"2008","journal-title":"Nature."},{"issue":"41","key":"10.1016\/j.bcp.2021.114747_b0875","doi-asserted-by":"crossref","first-page":"35795","DOI":"10.1074\/jbc.C111.269050","article-title":"Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation","volume":"286","author":"Liu","year":"2011","journal-title":"J Biol Chem."},{"issue":"19","key":"10.1016\/j.bcp.2021.114747_b0880","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1128\/MCB.00814-14","article-title":"Plk1 phosphorylation of PTEN Causes a tumor-promoting metabolic state","volume":"34","author":"Li","year":"2014","journal-title":"Mol Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0885","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3892\/or.2016.4820","article-title":"Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K\/Akt pathway via polo-like kinase 1","volume":"36","author":"Mao","year":"2016","journal-title":"Oncol Rep."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0890","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.tranon.2018.04.011","article-title":"Combination of PI3K\/Akt pathway inhibition and Plk1 depletion can enhance chemosensitivity to gemcitabine in pancreatic carcinoma","volume":"11","author":"Mao","year":"2018","journal-title":"Transl Oncol."},{"issue":"22","key":"10.1016\/j.bcp.2021.114747_b0895","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1158\/0008-5472.CAN-14-1916","article-title":"PIk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer","volume":"74","author":"Zhang","year":"2014","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bcp.2021.114747_b0900","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1158\/0008-5472.CAN-14-2928","article-title":"PLK1 and HOTAIR accelerate proteasomal degradation of SUZ12 and ZNF198 during hepatitis B virus-induced liver carcinogenesis","volume":"75","author":"Zhang","year":"2015","journal-title":"Cancer Res."},{"issue":"39","key":"10.1016\/j.bcp.2021.114747_b0905","doi-asserted-by":"crossref","first-page":"30282","DOI":"10.1074\/jbc.M109.093963","article-title":"Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy","volume":"285","author":"Studach","year":"2010","journal-title":"J Biol Chem."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0910","doi-asserted-by":"crossref","first-page":"12327","DOI":"10.1038\/s41598-020-69338-8","article-title":"Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer","volume":"10","author":"Gheghiani","year":"2020","journal-title":"Sci Rep."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0915","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molcel.2016.09.016","article-title":"Polo-like kinase-1 regulates Myc stabilization and activates a feedforward circuit promoting tumor cell survival","volume":"64","author":"Xiao","year":"2016","journal-title":"Mol Cell."},{"issue":"12","key":"10.1016\/j.bcp.2021.114747_b0920","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1172\/JCI122533","article-title":"PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas","volume":"128","author":"Ren","year":"2018","journal-title":"J Clin Invest."},{"issue":"24","key":"10.1016\/j.bcp.2021.114747_b0925","doi-asserted-by":"crossref","first-page":"9085","DOI":"10.1073\/pnas.0402770101","article-title":"The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation","volume":"101","author":"Welcker","year":"2004","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"10.1016\/j.bcp.2021.114747_b0930","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.7150\/thno.32908","article-title":"Polo-Like Kinase 1 phosphorylates and stabilizes KLF4 to promote tumorigenesis in nasopharyngeal carcinoma","volume":"9","author":"Mai","year":"2019","journal-title":"Theranostics."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0935","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bbrc.2020.09.008","article-title":"Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC","volume":"533","author":"Wang","year":"2020","journal-title":"Biochem Biophys Res Commun."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0940","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2011.11.023","article-title":"Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells","volume":"142","author":"Zhang","year":"2012","journal-title":"Gastroenterology."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0945","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41467-017-01647-5","article-title":"Polo-like kinase 1 coordinates biosynthesis during cell cycle progression by directly activating pentose phosphate pathway","volume":"8","author":"Ma","year":"2017","journal-title":"Nat Commun."},{"issue":"22","key":"10.1016\/j.bcp.2021.114747_b0950","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1128\/MCB.00392-08","article-title":"Polo-like kinase 1 Is essential for early embryonic development and tumor suppression","volume":"28","author":"Lu","year":"2008","journal-title":"Mol Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0955","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1038\/s41467-018-05429-5","article-title":"Plk1 overexpression induces chromosomal instability and suppresses tumor development","volume":"9","author":"de C\u00e1rcer","year":"2018","journal-title":"Nat Commun."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b0960","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.celrep.2013.05.024","article-title":"PLK1 signaling in breast cancer cells cooperates with estrogen receptor-dependent gene transcription","volume":"3","author":"Wierer","year":"2013","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0965","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-03494-4","article-title":"PLK1 has tumor-suppressive potential in APC-Truncated colon cancer cells","volume":"9","author":"Raab","year":"2018","journal-title":"Nat Commun."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b0970","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1128\/JVI.78.3.1464-1472.2004","article-title":"Dysregulation of the polo-like kinase pathway in CD4+ T cells is characteristic of pathogenic simian immunodeficiency virus infection","volume":"78","author":"Bostik","year":"2004","journal-title":"J Virol."},{"key":"10.1016\/j.bcp.2021.114747_b0975","doi-asserted-by":"crossref","unstructured":"Zhou D, Hayashi T, Jean M, Kong W, Fiches G, Biswas A, et al. Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4+ T cells ex vivo. Sci Adv. 2020;6(29):eaba1941.","DOI":"10.1126\/sciadv.aba1941"},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b0980","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-017-0420-1","article-title":"A novel form of necrosis, TRIAD, occurs in human huntington\u2019s disease","volume":"5","author":"Yamanishi","year":"2017","journal-title":"Acta Neuropathol Commun."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b0985","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ncomms1395","article-title":"Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells","volume":"19","author":"Raab","year":"2011","journal-title":"Nat Commun."},{"key":"10.1016\/j.bcp.2021.114747_b0990","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/705745","article-title":"PLK-1 targeted inhibitors and their potential against tumorigenesis","volume":"2015","author":"Kumar","year":"2015","journal-title":"Biomed Res Int."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b0995","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cub.2006.12.037","article-title":"BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo","volume":"17","author":"Steegmaier","year":"2007","journal-title":"Curr Biol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b1000","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nchembio.1471","article-title":"Dual kinase-bromodomain inhibitors for rationally designed polypharmacology","volume":"10","author":"Ciceri","year":"2014","journal-title":"Nat Chem Biol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b1005","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bjh.12518","article-title":"A randomized, open-label, phase I\/II trial to investigate the maximum tolerated dose of the polo-like kinase inhibitor BI 2536 in elderly patients with refractory\/relapsed acute myeloid leukaemia","volume":"163","author":"M\u00fcller-Tidow","year":"2013","journal-title":"Br J Haematol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114747_b1010","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/JTO.0b013e3181d95dd4","article-title":"The efficacy and safety of BI 2536, a novel Plk-1 inhibitor, in patients with stage IIIB\/IV non-small cell lung cancer who had relapsed after, or failed, chemotherapy: results from an open-label, randomized phase II clinical trial","volume":"5","author":"Sebastian","year":"2010","journal-title":"J Thorac Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b1015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/bjc.2012.257","article-title":"A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-na\u00efve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the central european society anticancer drug research (CESAR) collaborative network","volume":"107","author":"Mross","year":"2012","journal-title":"Br J Cancer."},{"issue":"12","key":"10.1016\/j.bcp.2021.114747_b1020","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.ejca.2010.03.039","article-title":"Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma","volume":"46","author":"Sch\u00f6ffski","year":"2010","journal-title":"Eur J Cancer."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b1025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12185-020-02994-8","article-title":"Phase 1 dose escalation trial of volasertib in combination with decitabine in patients with acute myeloid leukemia","volume":"113","author":"Cortes","year":"2021","journal-title":"Int J Hematol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114747_b1030","first-page":"3548","article-title":"Volasertib suppresses tumor growth and potentiates the activity of cisplatin in cervical cancer","volume":"5","author":"Xie","year":"2015","journal-title":"Am J Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114747_b1035","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/cas.14769","article-title":"Therapeutic inhibition of polo-like kinases in anaplastic thyroid cancer","volume":"112","author":"Lin","year":"2021","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b1040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1158\/1535-7163.MCT-20-0654","article-title":"PLK1 and NOTCH positively correlate in melanoma and their combined inhibition results in synergistic modulations of key melanoma pathways","volume":"20","author":"Su","year":"2021","journal-title":"Mol Cancer Ther."},{"issue":"60","key":"10.1016\/j.bcp.2021.114747_b1045","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.18632\/oncotarget.27237","article-title":"Volasertib preclinical activity in high-risk hepatoblastoma","volume":"10","author":"Kats","year":"2019","journal-title":"Oncotarget."},{"issue":"9","key":"10.1016\/j.bcp.2021.114747_b1050","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1182\/blood-2014-03-560557","article-title":"Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy","volume":"124","author":"D\u00f6hner","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.bcp.2021.114747_b1055","unstructured":"Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2) - Full Text View - ClinicalTrials.gov [Internet]."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b1060","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/1878-0261.12477","article-title":"In vitro study of the polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53","volume":"13","author":"Van den Bossche","year":"2019","journal-title":"Mol Oncol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b1065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cllc.2015.05.010","article-title":"A randomized, open-label phase II trial of volasertib as monotherapy and in combination with standard-dose pemetrexed compared with pemetrexed monotherapy in second-line treatment for non-small-cell lung cancer","volume":"16","author":"Ellis","year":"2015","journal-title":"Clin Lung Cancer."},{"issue":"7","key":"10.1016\/j.bcp.2021.114747_b1070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.2015.62.1474","article-title":"Volasertib versus chemotherapy in platinum-resistant or-refractory ovarian cancer: a randomized phase II groupe des investigateurs nationaux pour l\u2019etude des cancers de l\u2019ovaire study","volume":"34","author":"Pujade-Lauraine","year":"2016","journal-title":"J Clin Oncol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114747_b1075","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/cncr.28519","article-title":"An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer","volume":"120","author":"Stadler","year":"2014","journal-title":"Cancer."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b1080","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3390\/cancers12030672","article-title":"Identification of PLK1 as a new therapeutic target in mucinous ovarian carcinoma","volume":"12","author":"Affatato","year":"2020","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.bcp.2021.114747_b1085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224420","article-title":"Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer","author":"Giordano","year":"2019","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b1090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/CAD.0000000000000157","article-title":"BI 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments","volume":"26","author":"Bogado","year":"2015","journal-title":"Anticancer Drugs."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b1095","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.18632\/oncotarget.14268","article-title":"The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models","volume":"8","author":"Pajtler","year":"2017","journal-title":"Oncotarget."},{"issue":"23","key":"10.1016\/j.bcp.2021.114747_b1100","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1158\/1078-0432.CCR-20-2586","article-title":"A phase ib study of onvansertib, a novel oral PLK1 inhibitor, in combination therapy for patients with relapsed or refractory acute myeloid leukemia","volume":"26","author":"Zeidan","year":"2020","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.bcp.2021.114747_b1105","unstructured":"Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a Kras Mutation - Full Text View - ClinicalTrials.gov [Internet]."},{"key":"10.1016\/j.bcp.2021.114747_b1110","unstructured":"Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer - Full Text View - ClinicalTrials.gov [Internet]."},{"issue":"873","key":"10.1016\/j.bcp.2021.114747_b1115","article-title":"Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by \u03b11-blockers","volume":"15","author":"Wang","year":"2020","journal-title":"Eur J Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114747_b1120","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1016\/j.bmcl.2013.02.083","article-title":"Discovery of TAK-960: an orally available small molecule inhibitor of polo-like kinase 1 (PLK1)","volume":"23","author":"Nie","year":"2013","journal-title":"Bioorganic Med Chem Lett."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b1125","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1158\/1535-7163.MCT-11-0762","article-title":"TAK-960, a novel, orally available, selective inhibitor of polo-like kinase 1, shows broad-spectrum preclinical antitumor activity in multiple dosing regimens","volume":"11","author":"Hikichi","year":"2012","journal-title":"Mol Cancer Ther."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b1130","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1158\/1535-7163.MCT-11-0765","article-title":"NMS-P937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignancies","volume":"11","author":"Valsasina","year":"2012","journal-title":"Mol Cancer Ther."},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b1135","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s10637-014-0158-6","article-title":"Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance","volume":"32","author":"Sero","year":"2014","journal-title":"Invest New Drugs."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b1140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058424","article-title":"The polo-like kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia","volume":"8","author":"Casolaro","year":"2013","journal-title":"PLoS One."},{"issue":"10","key":"10.1016\/j.bcp.2021.114747_b1145","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.bmcl.2011.03.054","article-title":"NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective polo-like kinase 1 inhibitor","volume":"21","author":"Beria","year":"2011","journal-title":"Bioorganic Med Chem Lett."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b1150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10637-017-0491-7","article-title":"Phase I dose escalation study of NMS-1286937, an orally available polo-like kinase 1 inhibitor, in patients with advanced or metastatic solid tumors","volume":"36","author":"Weiss","year":"2018","journal-title":"Invest New Drugs."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b1155","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.chembiol.2008.03.013","article-title":"Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions","volume":"15","author":"Reindl","year":"2008","journal-title":"Chem Biol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b1160","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.ajpath.2011.06.031","article-title":"Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo","volume":"179","author":"Yuan","year":"2011","journal-title":"Am J Pathol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114747_b1165","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/15384101.2017.1325043","article-title":"Several inhibitors of the Plk1 polo-box domain turn out to be non-specific protein alkylators","volume":"16","author":"Archambault","year":"2017","journal-title":"Cell Cycle."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b1170","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ccr.2005.02.009","article-title":"ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent","volume":"7","author":"Gumireddy","year":"2005","journal-title":"Cancer Cell."},{"issue":"12","key":"10.1016\/j.bcp.2021.114747_b1175","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/onc.2008.502","article-title":"Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells","volume":"28","author":"Prasad","year":"2009","journal-title":"Oncogene."},{"issue":"3","key":"10.1016\/j.bcp.2021.114747_b1180","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cell.2016.03.045","article-title":"A small molecule RAS-mimetic disrupts RAS association with effector proteins to block signaling","volume":"165","author":"Athuluri-Divakar","year":"2016","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b1185","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.molcel.2020.06.008","article-title":"Pharmaceutical-Grade rigosertib is a microtubule-destabilizing agent","volume":"79","author":"Jost","year":"2020","journal-title":"Mol Cell."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b1190","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.molcel.2020.05.024","article-title":"A contaminant impurity, not rigosertib, is a tubulin binding agent","volume":"79","author":"Baker","year":"2020","journal-title":"Mol Cell."},{"issue":"1","key":"10.1016\/j.bcp.2021.114747_b1195","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.molcel.2017.09.012","article-title":"Combined CRISPRi\/a-based chemical genetic screens reveal that rigosertib is a microtubule-destabilizing agent","volume":"68","author":"Jost","year":"2017","journal-title":"Mol Cell."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b1200","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.molcel.2016.10.029","article-title":"Inhibition of Ras\/Raf\/MEK\/ERK pathway signaling by a stress-induced phospho-regulatory circuit","volume":"64","author":"Ritt","year":"2016","journal-title":"Mol Cell."},{"issue":"4","key":"10.1016\/j.bcp.2021.114747_b1205","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1470-2045(16)00009-7","article-title":"Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial","volume":"17","author":"Garcia-Manero","year":"2016","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114747_b1210","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/annonc\/mdv264","article-title":"A phase II\/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer","volume":"26","author":"O\u2019Neil","year":"2015","journal-title":"Ann Oncol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114747_b1215","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/leu.2013.79","article-title":"Phase i study of on 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed\/refractory B-cell malignancies","volume":"27","author":"Roschewski","year":"2013","journal-title":"Leukemia."},{"key":"10.1016\/j.bcp.2021.114747_b1220","unstructured":"Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma - Full Text View - ClinicalTrials.gov [Internet]."},{"key":"10.1016\/j.bcp.2021.114747_b1225","doi-asserted-by":"crossref","unstructured":"Garcia-Manero G, Fenaux P, Al-Kali A, Navada SC, Baer MR, Raza A, et al. Comprehensive Analysis of Safety: Rigosertib in 557 Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML). Blood. 2016;128(22):2011\u20132011.","DOI":"10.1182\/blood.V128.22.2011.2011"},{"issue":"6","key":"10.1016\/j.bcp.2021.114747_b1230","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1021\/cb200551p","article-title":"Enabling and disabling polo-like kinase 1 inhibition through chemical genetics","volume":"7","author":"Burkard","year":"2012","journal-title":"ACS Chem Biol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114747_b1235","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1158\/0008-5472.CAN-07-6182","article-title":"Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.bcp.2021.114747_b1240","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1128\/MCB.23.16.5556-5571.2003","article-title":"Silencing of the Novel p53 Target Gene Snk \/ Plk2 Leads to Mitotic Catastrophe in Paclitaxel (Taxol)-Exposed Cells","volume":"23","author":"Burns","year":"2003","journal-title":"Mol Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114747_b1245","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat Rev Immunol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:12:34Z","timestamp":1762096354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221003634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":249,"alternative-id":["S0006295221003634"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114747","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polo-like kinase 1 (PLK1) signaling in cancer and beyond","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114747"}}